Showing results (131-140 of 227) with videos related to
Sort By:
Pageof 23
Cancer Chemotherapy and Pharmacology|January 1, 1991
Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group studyS M Grunberg, J J Crowley, R B Livingston, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2013
BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groupsT Safra, W C Lai, L Borgato, et al.International Journal of Oncology|May 6, 2011
mRNA levels of molecular chaperones hsp27, hsp60 and hsp70 in cisplatin resistant squamous cell carcinomasB Nakata, D Hom, R Barton, et al.Annals of Internal Medicine|November 1, 1979
Risk factors for doxorubicin-induced congestive heart failureD D Von Hoff, M W Layard, P Basa, et al.The American Journal of Medicine|April 1, 1985
Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breastJ L Speyer, M D Green, N Dubin, et al.Journal of the National Cancer Institute|July 21, 1993
Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesisM S Ray, F M Muggia, C G Leichman, et al.Investigational New Drugs|February 1, 1991
Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group studyJ A Kish, K Kopecky, M K Samson, et al.International Journal of Oncology|May 12, 2011
Association between hsp60 messenger-RNA levels and Cisplatin resistance in human head and neck-cancer cell-linesB Nakata, R Barton, K Robbins, et al.Cancer Letters|May 30, 1990
The use of oxaliplatin versus cisplatin in intraperitoneal chemotherapy in cancers restricted to the peritoneal cavity in the ratG Los, P H Mutsaers, M Ruevekamp, et al.Cancer Research|December 1, 1993
Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease responseF A Blommaert, C Michael, P M Terheggen, et al.Pageof 23